Discover the top CPA prep courses, comparing Becker, Gleim, Surgent, and more. Explore features, pricing, and support to find ...

June 1 (Reuters) - Praxis Precision Medicines (PRAX.O), opens new tab said on Monday its experimental epilepsy drug failed to meet the main goal of a mid- to late-stage ‌study, prompting it to pause ...

Almost one in four white-collar workers is experiencing a hidden professional crisis: a "mid-career stall," defined as at least five years without a promotion or meaningful raise, new research shows.

More than 24% of mid-career U.S. professionals are employed but without a meaningful promotion or raise for five or more years — a phenomenon researchers call “mid-career stall” — according to a May ...

MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The large series of programming changes will put some familiar faces in new ...

Add Yahoo as a preferred source to see more of our stories on Google. MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The ...

The 2026 PCEP-30-02 exam now features interactive, scenario-based questions and updated domain weightings, requiring candidates to demonstrate applied Python skills under timed conditions. Official ...

Cell phone bans in schools are working—at least as far as keeping kids off their phones during school, according to a new working paper. But the bans, which have been touted by researchers, educators ...

New qualitative research shows that students who were admitted through test-optional admissions generally don’t feel underqualified to attend their institutions, despite claims otherwise from those ...

The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. This story also ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Researchers at ...